Fred Ledley, director of the Center for the Integration of Science and Industry, joins Vonnie Quinn on Bloomberg Radio’s "The Hays Advantage" to discuss whether the Food and Drug Administration should take a "customized" approach to drug approvals.
http://media.bloomberg.com/bb/avfile/Economics/On_Economy/v20SF9_u8pgE.mp3
